Zwart, Aniek T. http://orcid.org/0000-0002-9770-4754
Becker, Jan-Niklas
Lamers, Maria J.
Dierckx, Rudi A. J. O.
de Bock, Geertruida H.
Halmos, Gyorgy B.
van der Hoorn, Anouk
Funding for this research was provided by:
graduate school of medical sciences of the university of Groningen (3-year PhD scholarship for excellent master students)
Article History
Received: 4 May 2020
Revised: 17 August 2020
Accepted: 22 October 2020
First Online: 21 November 2020
Compliance with ethical standards
:
: The scientific guarantor of this publication is A. van der Hoorn.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) by OncoLifeS in this study.
: OncoLifeS is a large oncological data-biobank which is approved by the Medical Ethical Committee of the University Medical Centre of Groningen. The scientific board of OncoLifeS gave permission to use the data for this present study.
: In this current manuscript, data of 50 of the 125 patients have been reported previously by Zwart et al in Zwart AT, van der Hoorn A, van Ooijen, P M A, Steenbakkers, R J H M, de Bock GH, Halmos GB (2019) “CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.” <i>J Cachexia Sarcopenia Muscle</i>. In the previously published study, we quantified pre-treatment skeletal muscle mass on neck CT images and no neck MRI images were used. None of the MRI measurements has been published earlier.
: • Retrospective analysis on prospectively included data• Cross-sectional study• Performed at one institution